NVO
NYSE
$49.61
Novo Nordisk (NVO)
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Hold
Target: $47.52 (-4.21%)
Market Cap
$225B
PEG Ratio
0.44
EPS 5Y CAGR
+24.26%
Revenue 5Y CAGR
+20.75%
Price Chart
Valuation
Market Cap$225B
P/E11.79
Forward P/E14.97
PEG0.44
P/S0.66
P/B7.07
Profitability
Total Revenue (TTM)$51B
Gross Profit (TTM)$42B
EBITDA$29B
Profit Margin50.1%
Operating Margin61.6%
EPS$4.29
Financial Health
Debt-to-Equity72.1%
Free Cash Flow Yield1.98%
Dividend Yield3.58%
Growth & Risk
EPS 5Y CAGR+24.26%
Revenue 5Y CAGR+20.75%
FCF 5Y CAGR-6.57%
Dividends 5Y CAGR+31.66%
Beta (5Y)0.90
Sharpe Ratio-0.25